ATE430737T1 - Lithium-komplexe von n-(1-hydroxymethyl-2,3- dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7, 0-tetraazacyclododecan, deren herstellung und verwendung - Google Patents
Lithium-komplexe von n-(1-hydroxymethyl-2,3- dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7, 0-tetraazacyclododecan, deren herstellung und verwendungInfo
- Publication number
- ATE430737T1 ATE430737T1 AT01991788T AT01991788T ATE430737T1 AT E430737 T1 ATE430737 T1 AT E430737T1 AT 01991788 T AT01991788 T AT 01991788T AT 01991788 T AT01991788 T AT 01991788T AT E430737 T1 ATE430737 T1 AT E430737T1
- Authority
- AT
- Austria
- Prior art keywords
- triscarboxymethyl
- tetraazacyclododecan
- dihydroxypropyl
- hydroxymethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/02—Lithium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10064467A DE10064467C2 (de) | 2000-12-15 | 2000-12-15 | Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung |
| PCT/EP2001/014283 WO2002048119A2 (de) | 2000-12-15 | 2001-12-05 | Lithium-komplexe von n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE430737T1 true ATE430737T1 (de) | 2009-05-15 |
Family
ID=7668584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01991788T ATE430737T1 (de) | 2000-12-15 | 2001-12-05 | Lithium-komplexe von n-(1-hydroxymethyl-2,3- dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7, 0-tetraazacyclododecan, deren herstellung und verwendung |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6894151B2 (cs) |
| EP (1) | EP1343770B1 (cs) |
| JP (1) | JP4399163B2 (cs) |
| KR (1) | KR100869627B1 (cs) |
| CN (1) | CN1229357C (cs) |
| AR (1) | AR035609A1 (cs) |
| AT (1) | ATE430737T1 (cs) |
| AU (2) | AU2002231659B2 (cs) |
| BG (1) | BG66117B1 (cs) |
| BR (1) | BR0116219A (cs) |
| CA (1) | CA2431976C (cs) |
| CY (1) | CY1109280T1 (cs) |
| CZ (1) | CZ304573B6 (cs) |
| DE (2) | DE10064467C2 (cs) |
| DK (1) | DK1343770T3 (cs) |
| EC (1) | ECSP034676A (cs) |
| EE (1) | EE05245B1 (cs) |
| ES (1) | ES2325982T3 (cs) |
| HR (1) | HRP20030576B1 (cs) |
| HU (1) | HU229657B1 (cs) |
| IL (1) | IL156432A0 (cs) |
| ME (1) | ME00157B (cs) |
| MX (1) | MXPA03005240A (cs) |
| NO (1) | NO324864B1 (cs) |
| NZ (1) | NZ526478A (cs) |
| PL (1) | PL204181B1 (cs) |
| PT (1) | PT1343770E (cs) |
| RS (1) | RS51862B (cs) |
| RU (1) | RU2003120513A (cs) |
| SK (1) | SK287424B6 (cs) |
| TW (1) | TWI302531B (cs) |
| UY (1) | UY27056A1 (cs) |
| WO (1) | WO2002048119A2 (cs) |
| ZA (1) | ZA200305421B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004112840A2 (en) * | 2003-06-25 | 2004-12-29 | Guerbet | Peptide conjugate for magnetic resonance imaging |
| FR2867473B1 (fr) | 2004-03-12 | 2006-06-23 | Guerbet Sa | Compose de porphyrines et utilisation a haut champ en irm |
| ATE429933T1 (de) * | 2004-07-02 | 2009-05-15 | Bracco Imaging Spa | 1,4-bis(carboxymethyl)-6- |
| CN101400661A (zh) * | 2006-03-14 | 2009-04-01 | 马林克罗特公司 | 四氮杂大环衍生物的金属络合物 |
| US7777029B2 (en) * | 2006-05-02 | 2010-08-17 | San Diego State University (Sdsu) Foundation | Bifunctional chelators for sequestering lanthanides |
| DE102009053252B3 (de) * | 2009-11-09 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels keramischer Membran |
| DE102009057274B4 (de) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels Trioxobicyclo-octan |
| WO2011054480A1 (de) | 2009-11-09 | 2011-05-12 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels keramischer membran |
| DE102010013833A1 (de) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Herstellung von Gadobutrol mittels Dimethylformamiddimethylacetal |
| DE102010023105A1 (de) | 2010-06-04 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol |
| KR20190079682A (ko) | 2011-04-21 | 2019-07-05 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 고순도 가도부트롤의 제조 |
| CN106543094A (zh) * | 2016-11-04 | 2017-03-29 | 嘉实（湖南）医药科技有限公司 | 高纯度钆布醇的制备方法 |
| KR101971435B1 (ko) * | 2017-08-29 | 2019-04-24 | 주식회사 엔지켐생명과학 | 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법 |
| KR102033964B1 (ko) * | 2018-01-19 | 2019-10-18 | 주식회사 엔지켐생명과학 | 가도테리돌 중간체 및 이를 이용한 가도테리돌 제조방법 |
| CN111039885B (zh) * | 2019-12-06 | 2021-03-05 | 广州康瑞泰药业有限公司 | 一种制备高纯度考布曲钙的方法 |
| KR20210112910A (ko) * | 2020-03-06 | 2021-09-15 | 주식회사 엔지켐생명과학 | 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4009119A1 (de) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| DE19724186C2 (de) * | 1997-06-02 | 2002-07-18 | Schering Ag | Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe |
-
2000
- 2000-12-15 DE DE10064467A patent/DE10064467C2/de not_active Expired - Lifetime
-
2001
- 2001-11-07 TW TW090127671A patent/TWI302531B/zh not_active IP Right Cessation
- 2001-12-05 JP JP2002549650A patent/JP4399163B2/ja not_active Expired - Lifetime
- 2001-12-05 NZ NZ526478A patent/NZ526478A/en not_active IP Right Cessation
- 2001-12-05 AU AU2002231659A patent/AU2002231659B2/en not_active Expired
- 2001-12-05 BR BRPI0116219-5A patent/BR0116219A/pt not_active IP Right Cessation
- 2001-12-05 ES ES01991788T patent/ES2325982T3/es not_active Expired - Lifetime
- 2001-12-05 RS YU48103A patent/RS51862B/sr unknown
- 2001-12-05 AU AU3165902A patent/AU3165902A/xx active Pending
- 2001-12-05 PT PT01991788T patent/PT1343770E/pt unknown
- 2001-12-05 IL IL15643201A patent/IL156432A0/xx active IP Right Grant
- 2001-12-05 PL PL366141A patent/PL204181B1/pl unknown
- 2001-12-05 CZ CZ2003-1641A patent/CZ304573B6/cs not_active IP Right Cessation
- 2001-12-05 RU RU2003120513/04A patent/RU2003120513A/ru not_active Application Discontinuation
- 2001-12-05 WO PCT/EP2001/014283 patent/WO2002048119A2/de active IP Right Grant
- 2001-12-05 HU HU0302563A patent/HU229657B1/hu unknown
- 2001-12-05 EP EP01991788A patent/EP1343770B1/de not_active Expired - Lifetime
- 2001-12-05 DK DK01991788T patent/DK1343770T3/da active
- 2001-12-05 AT AT01991788T patent/ATE430737T1/de active
- 2001-12-05 CA CA2431976A patent/CA2431976C/en not_active Expired - Lifetime
- 2001-12-05 ME MEP-2008-157A patent/ME00157B/me unknown
- 2001-12-05 SK SK729-2003A patent/SK287424B6/sk not_active IP Right Cessation
- 2001-12-05 DE DE50114889T patent/DE50114889D1/de not_active Expired - Lifetime
- 2001-12-05 KR KR1020037008035A patent/KR100869627B1/ko not_active Expired - Lifetime
- 2001-12-05 UY UY27056A patent/UY27056A1/es not_active Application Discontinuation
- 2001-12-05 CN CNB018206808A patent/CN1229357C/zh not_active Expired - Lifetime
- 2001-12-05 EE EEP200300282A patent/EE05245B1/xx unknown
- 2001-12-05 MX MXPA03005240A patent/MXPA03005240A/es active IP Right Grant
- 2001-12-05 HR HR20030576A patent/HRP20030576B1/xx not_active IP Right Cessation
- 2001-12-13 US US10/013,840 patent/US6894151B2/en not_active Expired - Lifetime
- 2001-12-14 AR ARP010105797A patent/AR035609A1/es unknown
-
2003
- 2003-06-04 NO NO20032523A patent/NO324864B1/no not_active IP Right Cessation
- 2003-06-12 BG BG107901A patent/BG66117B1/bg unknown
- 2003-06-26 EC EC2003004676A patent/ECSP034676A/es unknown
- 2003-07-14 ZA ZA200305421A patent/ZA200305421B/en unknown
-
2009
- 2009-08-06 CY CY20091100837T patent/CY1109280T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE430737T1 (de) | Lithium-komplexe von n-(1-hydroxymethyl-2,3- dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7, 0-tetraazacyclododecan, deren herstellung und verwendung | |
| DE60229061D1 (de) | Herstellung und verwendung von nanopartikel | |
| DE60025147D1 (de) | Kosmetische Zusammensetzung und Verwendungen | |
| CY2008019I1 (el) | Υποκατεστημενες οξαζολιδινονες και η χρηση των στο πεδιο της πηξης αιματος | |
| DE69839279D1 (de) | Neue physiologisch aktive substanz sulphostin, herstellung und verwendung derselben | |
| DE60038200D1 (de) | ren Herstellung und Verwendung | |
| ATE296302T1 (de) | 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung | |
| DE69929879D1 (de) | Herstellung von acetal-derivatisierten hydroxylaromatischen polymeren und ihre verwendung in strahlungsempfindlichen formulierungen | |
| DE60107859D1 (de) | Benzimidazolderivate, ihre herstellung und therapeutische verwendung | |
| EP1299415A4 (en) | MODULATOR OF THE CHEMOKINE RECEPTOR, PRODUCTION AND USE THEREOF | |
| DE69715482D1 (de) | Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan | |
| ATE259357T1 (de) | Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament | |
| ATE231869T1 (de) | Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung | |
| DE60013021D1 (de) | Herstellung von S,S und R,S Aminosäuren-Isosteren | |
| DE69934889D1 (de) | Herstellung und reinigung von diboranen | |
| DE50002417D1 (de) | 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung | |
| AU2002231659A1 (en) | Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof | |
| DE69534632T2 (de) | Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit | |
| DE59912915D1 (de) | Herstellung von 4,4'-Diketo-carotinoiden | |
| NO20030220D0 (no) | Ny form av (R)-N-[5-metyl-8-(4-metylpiperazin-1-yl)-1,2,3,4- tetrahydro-2-naftyl]-4-morfolinobenzamid | |
| DE10195737T1 (de) | Hautgummiermittel und kosmetische Formulierungen | |
| DE60109397D1 (de) | Alkyl-substituierte Derivate von 4,5,6,7-Tetrahydro-4-indan und deren Verwendung in Parfümzubereitungen | |
| ATE237584T1 (de) | Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung | |
| DE59501950D1 (de) | Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung | |
| DE60002866D1 (de) | Echinocandinderivate, deren herstellung und verwendung als fungizid |